| Ashley Delserro, RN | |
|
4075 E Market St Ste 20, York, PA 17402-5123 | |
| (717) 244-8504 | |
| (717) 244-5401 |
| Full Name | Ashley Delserro |
|---|---|
| Gender | Female |
| Speciality | Pain Medicine - Pain Medicine |
| Location | 4075 E Market St Ste 20, York, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306560701 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | SP026349 (Pennsylvania) | Primary |
| Entity Name | Jb Pain Free Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316441017 PECOS PAC ID: 9234494584 Enrollment ID: O20180607001836 |
News Archive
An international research team under the co-direction of the University of Bern and the Netherlands Cancer Institute has discovered various mechanisms of resistance to cancer therapy. The findings help researchers to understand the self-repair of cancer cells after a therapy and thus help to fight resistant tumours more efficiently.
Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today the resubmission of Impax's New Drug Application (NDA) for RYTARY (IPX066) to the U.S. Food and Drug Administration (FDA).
Marilyn Bartlett, the director administrator of Montana's Health Care and Benefits Division, recalls thinking "holy cow" when she got an urgent directive from state legislators in late 2014: "You have to get these costs under control, or else."
Using functional magnetic resonance imaging (fMRI), researchers have identified abnormalities in the brains of children with attention deficit/hyperactivity disorder (ADHD) that may serve as a biomarker for the disorder, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Cancer development is a complex process involving both genetic and epigenetic changes. Genetic changes in oncogenes and tumor-suppressor genes are generally considered as primary causes, since these genes may directly regulate cellular growth. In addition, it has been found that changes in epigenetic factors, through mutation or altered gene expression, may contribute to cancer development.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Delserro, RN 4075 E Market St Ste 20, York, PA 17402-5123 Ph: (717) 244-8504 | Ashley Delserro, RN 4075 E Market St Ste 20, York, PA 17402-5123 Ph: (717) 244-8504 |
News Archive
An international research team under the co-direction of the University of Bern and the Netherlands Cancer Institute has discovered various mechanisms of resistance to cancer therapy. The findings help researchers to understand the self-repair of cancer cells after a therapy and thus help to fight resistant tumours more efficiently.
Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today the resubmission of Impax's New Drug Application (NDA) for RYTARY (IPX066) to the U.S. Food and Drug Administration (FDA).
Marilyn Bartlett, the director administrator of Montana's Health Care and Benefits Division, recalls thinking "holy cow" when she got an urgent directive from state legislators in late 2014: "You have to get these costs under control, or else."
Using functional magnetic resonance imaging (fMRI), researchers have identified abnormalities in the brains of children with attention deficit/hyperactivity disorder (ADHD) that may serve as a biomarker for the disorder, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Cancer development is a complex process involving both genetic and epigenetic changes. Genetic changes in oncogenes and tumor-suppressor genes are generally considered as primary causes, since these genes may directly regulate cellular growth. In addition, it has been found that changes in epigenetic factors, through mutation or altered gene expression, may contribute to cancer development.
› Verified 7 days ago
Edward S Kim, D.O. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 228 Saint Charles Way Ste 300, York, PA 17402 Phone: 717-812-2055 Fax: 717-741-3784 |